Evaluation the clinical trial of Rituximab (Zytux) efficacy in improving the skin stiffness and lung involvements of the patients with diffuse cutaneous Systemic sclerosis with diffuse skin involvement

Trial Profile

Evaluation the clinical trial of Rituximab (Zytux) efficacy in improving the skin stiffness and lung involvements of the patients with diffuse cutaneous Systemic sclerosis with diffuse skin involvement

Recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Sep 2016

At a glance

  • Drugs Rituximab (Primary) ; Diphenhydramine; Hydrocortisone
  • Indications Scleroderma
  • Focus Adverse reactions
  • Sponsors AryoGen Pharmed
  • Most Recent Events

    • 20 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top